BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 28449808)

  • 21. Versatile ion S5XL sequencer for targeted next generation sequencing of solid tumors in a clinical laboratory.
    Mehrotra M; Duose DY; Singh RR; Barkoh BA; Manekia J; Harmon MA; Patel KP; Routbort MJ; Medeiros LJ; Wistuba II; Luthra R
    PLoS One; 2017; 12(8):e0181968. PubMed ID: 28767674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation of archival formalin-fixed paraffin-embedded mouse liver samples for use with the Agilent gene expression microarray platform.
    Jackson AF; Williams A; Moffat I; Phillips SL; Recio L; Waters MD; Lambert IB; Yauk CL
    J Pharmacol Toxicol Methods; 2013; 68(2):260-268. PubMed ID: 23458726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Whole-Transcriptome profiling of formalin-fixed, paraffin-embedded renal cell carcinoma by RNA-seq.
    Li P; Conley A; Zhang H; Kim HL
    BMC Genomics; 2014 Dec; 15(1):1087. PubMed ID: 25495041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single-Center Experience with a Targeted Next Generation Sequencing Assay for Assessment of Relevant Somatic Alterations in Solid Tumors.
    Paasinen-Sohns A; Koelzer VH; Frank A; Schafroth J; Gisler A; Sachs M; Graber A; Rothschild SI; Wicki A; Cathomas G; Mertz KD
    Neoplasia; 2017 Mar; 19(3):196-206. PubMed ID: 28161563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Precise ERBB2 copy number assessment in breast cancer by means of molecular inversion probe array analysis.
    Christgen M; van Luttikhuizen JL; Raap M; Braubach P; Schmidt L; Jonigk D; Feuerhake F; Lehmann U; Schlegelberger B; Kreipe HH; Steinemann D
    Oncotarget; 2016 Dec; 7(50):82733-82740. PubMed ID: 27716627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Novel Next-Generation Sequencing-Based Approach for Concurrent Detection of Mitochondrial DNA Copy Number and Mutation.
    Zhou K; Mo Q; Guo S; Liu Y; Yin C; Ji X; Guo X; Xing J
    J Mol Diagn; 2020 Dec; 22(12):1408-1418. PubMed ID: 33011442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Copy number changes of clinically actionable genes in melanoma, non-small cell lung cancer and colorectal cancer-A survey across 822 routine diagnostic cases.
    Pfarr N; Penzel R; Klauschen F; Heim D; Brandt R; Kazdal D; Jesinghaus M; Herpel E; Schirmacher P; Warth A; Weichert W; Endris V; Stenzinger A
    Genes Chromosomes Cancer; 2016 Nov; 55(11):821-33. PubMed ID: 27218826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A computational tool to detect DNA alterations tailored to formalin-fixed paraffin-embedded samples in cancer clinical sequencing.
    Kato M; Nakamura H; Nagai M; Kubo T; Elzawahry A; Totoki Y; Tanabe Y; Furukawa E; Miyamoto J; Sakamoto H; Matsumoto S; Sunami K; Arai Y; Suzuki Y; Yoshida T; Tsuchihara K; Tamura K; Yamamoto N; Ichikawa H; Kohno T; Shibata T
    Genome Med; 2018 Jun; 10(1):44. PubMed ID: 29880027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Close correlation of copy number aberrations detected by next-generation sequencing with results from routine cytogenetics in acute myeloid leukemia.
    Vosberg S; Herold T; Hartmann L; Neumann M; Opatz S; Metzeler KH; Schneider S; Graf A; Krebs S; Blum H; Baldus CD; Hiddemann W; Spiekermann K; Bohlander SK; Mansmann U; Greif PA
    Genes Chromosomes Cancer; 2016 Jul; 55(7):553-67. PubMed ID: 27015608
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessing copy number alterations in targeted, amplicon-based next-generation sequencing data.
    Grasso C; Butler T; Rhodes K; Quist M; Neff TL; Moore S; Tomlins SA; Reinig E; Beadling C; Andersen M; Corless CL
    J Mol Diagn; 2015 Jan; 17(1):53-63. PubMed ID: 25468433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quality control material for the detection of somatic mutations in fixed clinical specimens by next-generation sequencing.
    Dumur CI; Almenara JA; Powers CN; Ferreira-Gonzalez A
    Diagn Pathol; 2015 Sep; 10():169. PubMed ID: 26376646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-Resolution Copy Number Patterns From Clinically Relevant FFPE Material.
    Filia A; Droop A; Harland M; Thygesen H; Randerson-Moor J; Snowden H; Taylor C; Diaz JMS; Pozniak J; Nsengimana J; Laye J; Newton-Bishop JA; Bishop DT
    Sci Rep; 2019 Jun; 9(1):8908. PubMed ID: 31222134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Large fragment Bst DNA polymerase for whole genome amplification of DNA from formalin-fixed paraffin-embedded tissues.
    Aviel-Ronen S; Qi Zhu C; Coe BP; Liu N; Watson SK; Lam WL; Tsao MS
    BMC Genomics; 2006 Dec; 7():312. PubMed ID: 17156491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous detection of BRCA mutations and large genomic rearrangements in germline DNA and FFPE tumor samples.
    Enyedi MZ; Jaksa G; Pintér L; Sükösd F; Gyuris Z; Hajdu A; Határvölgyi E; Priskin K; Haracska L
    Oncotarget; 2016 Sep; 7(38):61845-61859. PubMed ID: 27533253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a robust DNA quality and quantity assessment qPCR assay for targeted next-generation sequencing library preparation.
    Dang J; Mendez P; Lee S; Kim JW; Yoon JH; Kim TW; Sailey CJ; Jablons DM; Kim IJ
    Int J Oncol; 2016 Oct; 49(4):1755-65. PubMed ID: 27511764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of OncoPanel: A Targeted Next-Generation Sequencing Assay for the Detection of Somatic Variants in Cancer.
    Garcia EP; Minkovsky A; Jia Y; Ducar MD; Shivdasani P; Gong X; Ligon AH; Sholl LM; Kuo FC; MacConaill LE; Lindeman NI; Dong F
    Arch Pathol Lab Med; 2017 Jun; 141(6):751-758. PubMed ID: 28557599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multicenter validation of cancer gene panel-based next-generation sequencing for translational research and molecular diagnostics.
    Hirsch B; Endris V; Lassmann S; Weichert W; Pfarr N; Schirmacher P; Kovaleva V; Werner M; Bonzheim I; Fend F; Sperveslage J; Kaulich K; Zacher A; Reifenberger G; Köhrer K; Stepanow S; Lerke S; Mayr T; Aust DE; Baretton G; Weidner S; Jung A; Kirchner T; Hansmann ML; Burbat L; von der Wall E; Dietel M; Hummel M
    Virchows Arch; 2018 Apr; 472(4):557-565. PubMed ID: 29374318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amplicon-Based Targeted Next-Generation Sequencing of Formalin-Fixed, Paraffin-Embedded Tissue.
    Strengman E; Barendrecht-Smouter FAS; de Voijs C; de Vree P; Nijman IJ; de Leng WWJ
    Methods Mol Biol; 2019; 1908():1-17. PubMed ID: 30649717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Performance validation of an amplicon-based targeted next-generation sequencing assay and mutation profiling of 648 Chinese colorectal cancer patients.
    Wang Y; Liu H; Hou Y; Zhou X; Liang L; Zhang Z; Shi H; Xu S; Hu P; Zheng Z; Liu R; Tang T; Ye F; Liang Z; Bu H
    Virchows Arch; 2018 Jun; 472(6):959-968. PubMed ID: 29705968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High quality genomic copy number data from archival formalin-fixed paraffin-embedded leiomyosarcoma: optimisation of universal linkage system labelling.
    Salawu A; Ul-Hassan A; Hammond D; Fernando M; Reed M; Sisley K
    PLoS One; 2012; 7(11):e50415. PubMed ID: 23209738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.